Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

m6A-dependent glycolysis enhances colorectal cancer progression
Chaoqin Shen, Baoqin Xuan, Tingting Yan, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 322

Showing 1-25 of 322 citing articles:

The role of m6A RNA methylation in cancer metabolism
Yuanyuan An, Hua Duan
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 473
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 424
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
Jia Xiong, Jia He, Jun Zhu, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1660-1677.e10
Open Access | Times Cited: 403
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation
Qing Li, Yong Ni, Liren Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 282
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 257
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer
Jingzi Wang, Wei Zhu, Jie Han, et al.
Cancer Communications (2021) Vol. 41, Iss. 7, pp. 560-575
Open Access | Times Cited: 177
The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 172
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
Xinyang Zhong, Xuefeng He, Yaxian Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 152
Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification
Yiyang Hu, Chunli Gong, Zhibin Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 145
METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy
Yueqin Sun, Weitao Shen, Shulu Hu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 124
METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification
Yiming Xu, Dandan Lv, Chao Yan, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 120
Fusobacterium Nucleatum Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 Signaling
Cheng Kong, Xuebing Yan, Yefei Zhu, et al.
Cancer Research (2021) Vol. 81, Iss. 17, pp. 4485-4498
Open Access | Times Cited: 119
The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ
Xia Wang, Yuge Ji, Panpan Feng, et al.
Advanced Science (2021) Vol. 8, Iss. 13
Open Access | Times Cited: 108
FTO modifies the m6A level of MALAT and promotes bladder cancer progression
Le Tao, Xingyu Mu, Haige Chen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 106
N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma
Binbin Chen, Wei Jiang, Ying Huang, et al.
Oncogene (2022) Vol. 41, Iss. 15, pp. 2239-2253
Closed Access | Times Cited: 88
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 86
The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer
Deepthi Ramesh, Sònia Guil
Seminars in Cancer Biology (2022) Vol. 86, pp. 18-31
Open Access | Times Cited: 73
The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma
Lifang Ma, Xiangfei Xue, Xiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 71
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 58
m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 48
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
Tianyu Zhu, Lian‐Lian Hong, Zhi‐Qiang Ling
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 45
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top